These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4793528)

  • 1. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.
    Gill SD; Furesz J
    Arch Gesamte Virusforsch; 1973; 43(1):135-43. PubMed ID: 4793528
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo properties of attenuated rubella virus, "Cendehill" strain.
    Zygraich N; Peetermans J; Huygelen C
    Arch Gesamte Virusforsch; 1971; 33(3):225-33. PubMed ID: 5000190
    [No Abstract]   [Full Text] [Related]  

  • 3. An immunologic marker technique for the Cendehill vaccine strain of rubella virus.
    Oxford JS; Potter CW
    J Immunol; 1970 Oct; 105(4):818-23. PubMed ID: 5470523
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of the rabbit immunogenic marker of RA 27-3 rubella vaccine virus after human passage.
    Linnemann CC; Hutchinson L; Rotte TC; Hegg ME; Schiff GM
    Infect Immun; 1974 Mar; 9(3):547-9. PubMed ID: 4206028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells.
    Huygelen C; Peetermans J; Prinzie A
    Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell mediated immunity in experimental rubella infections.
    Cappel R
    Arch Virol; 1975; 47(4):375-9. PubMed ID: 1137503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.
    Plotkin SA; Farquhar JD; Ogra PL
    JAMA; 1973 Aug; 225(6):585-90. PubMed ID: 4740523
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
    Grillner L
    Scand J Infect Dis; 1975; 7(3):169-72. PubMed ID: 1237176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trials with a live attenuated rubella virus vaccine, Cendehill strain.
    Grant L; Belle EA; Provan G; King SD; Sigel MM
    J Hyg (Lond); 1970 Sep; 68(3):505-10. PubMed ID: 5272349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and immune response to rubella subunits vaccines.
    Cappel R; De Cuyper F
    Arch Virol; 1976; 50(3):207-13. PubMed ID: 1259596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.
    Freestone DS; Reynolds GM; McKinnon JA; Prydie J
    Br J Prev Soc Med; 1975 Dec; 29(4):258-61. PubMed ID: 766879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated rubella virus vaccines in young adult women. Trials of Cendehill and HPV-77 DE-5.
    Byrne EB; Ryan JM; Randolph MF; Horstmann DM
    Am J Dis Child; 1969 Aug; 118(2):234-6. PubMed ID: 4183351
    [No Abstract]   [Full Text] [Related]  

  • 14. Rubella antibody persistence after immunization.
    Herrmann KL; Halstead SB; Wiebenga NH
    JAMA; 1982 Jan; 247(2):193-6. PubMed ID: 7053457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of possible transplacental infection with rubella vaccination during pregnancy.
    Bolognese RJ; Corson SL; Fuccillo DA; Sever JL; Traub R
    Am J Obstet Gynecol; 1973 Dec; 117(7):939-41. PubMed ID: 4759831
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
    Minekawa Y; Takahashi M; Ueda S; Ogino T
    Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular and biologic characteristics of attenuated rubella viruses].
    Lavrent'eva IN
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (4):55-9. PubMed ID: 18819408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the response of lymphocytes to phytohemagglutinin in rubella.
    McMorrow LE; Vesikari T; Wolman SR; Giles JP; Cooper LZ
    J Infect Dis; 1974 Nov; 130(5):464-9. PubMed ID: 4423757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.